If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSyncona Regulatory News (SYNC)

Share Price Information for Syncona (SYNC)

Share Price is delayed by 15 minutes
Get Live Data
109.00    1.60 (1.49%)
Bid:
108.60
Ask:
109.00
Spread: 0.40 (0.368%)
Market Cap: £662.93m
SYNC Live PriceLast checked at - London Stock Exchange

Intraday Syncona Share Chart

Total Voting Rights

30 Dec 2016 11:33

Syncona Limited - Total Voting Rights

Syncona Limited - Total Voting Rights

PR Newswire

London, December 30

30 December 2016

Syncona Limited(the “Company”)

Total Voting Rights

In conformity with the FCA’s Disclosure Rules and Transparency Rules (the “Rules”) the Company would like to notify the market of the following:

As at 30 December 2016 the issued share capital of the Company comprises of 658,387,407 Ordinary Shares.

The total number of voting rights in the Company is therefore 658,387,407 which may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to, their interest in the Company under the Rules.

Enquiries:

Company website: www.synconaltd.com

Northern Trust International Fund Administration Services (Guernsey) LimitedCompany SecretaryTel: 01481 745001

Date   Source Headline
17th Jun 20217:00 amRNSFinal Results
17th Jun 20217:00 amRNSSyncona announces expansion of leadership team
11th Jun 202112:05 pmRNSAutolus to present additional data in AUTO1
18th May 20217:00 amRNSNotice of Results
18th May 20217:00 amRNSFreeline reports Q1 results
12th May 20213:05 pmRNSAutolus to present additional data in AUTO1
12th May 20211:18 pmRNSDirector/PDMR Shareholding
11th May 202112:05 pmRNSAchilles reports Q1 financial results
7th May 20217:00 amRNSGyroscope Therapeutics update on proposed IPO
6th May 202112:05 pmRNSAutolus reports Q1 2021 Financial Results
4th May 20217:00 amRNSUpdate on Gyroscope proposed IPO in the US
19th Apr 202112:05 pmRNSAutolus appoints non-executive Chair
19th Apr 20217:00 amRNSGyroscope files registration statement
6th Apr 20214:00 pmRNSDirector/PDMR Shareholding
1st Apr 20217:00 amRNSFreeline Reports Financial Results
31st Mar 20217:00 amRNSAchilles update on IPO
30th Mar 202112:04 pmRNSDirector/PDMR Shareholding
26th Mar 20217:06 amRNSGyroscope announces additional financing plans
26th Mar 20217:00 amRNSSyncona cornerstones $148m Series C in Gyroscope
25th Mar 202111:13 amRNSUpdate on Achilles’ proposed IPO
4th Mar 202112:10 pmRNSAutolus Reports Full Year 2020 Financial Results
2nd Mar 20217:00 amRNSAchilles files registration statement
12th Feb 20213:49 pmRNSGyroscope Announces Positive Interim Data
11th Feb 20217:00 amRNSNew commitment to Quell in largest ever Series A
11th Feb 20217:00 amRNSQuarterly and Business Update
10th Feb 20217:00 amRNSAutolus announces pricing of public offering
8th Feb 202112:09 pmRNSFreeline Updates Clinical Development Plan
5th Feb 20217:00 amRNSAchilles announces additional financing plans
5th Feb 20217:00 amRNSAchilles data and safety committee review
6th Jan 20217:00 amRNSAutolus Business Outlook
21st Dec 20207:00 amRNSVirginia Holmes Appointed Non-Executive Director
14th Dec 202012:05 pmRNSFreeline reports updated clinical data
7th Dec 20205:05 pmRNSAutolus presents additional data on AUTO3
7th Dec 20207:05 amRNSAutolus presents additional data on AUTO1
27th Nov 20204:35 pmRNSPrice Monitoring Extension
19th Nov 20207:00 amRNSSyncona founds Purespring with a £45m Series A
19th Nov 20207:00 amRNSHalf-year Report
5th Nov 202012:11 pmRNSAutolus reports Q3 2020 Financial Results
3rd Nov 20208:30 amRNSNotice of Results
2nd Nov 20207:00 amRNSDirectorate Change
30th Oct 20207:00 amRNSFreeline H1 Results and Business Highlights
18th Sep 20208:10 amRNSAutolus presents additional data on AUTO3
14th Sep 20201:05 pmRNSSyncona expands cell therapy portfolio
7th Sep 202012:07 pmRNSSecond Price Monitoring Extn
7th Sep 202012:02 pmRNSPrice Monitoring Extension
10th Aug 20207:00 amRNSQuarterly Update
7th Aug 20207:00 amRNSFreeline update on IPO
6th Aug 202012:10 pmRNSAutolus reports Q2 2020 Financial Results
3rd Aug 202011:30 amRNSUpdate on Freeline proposed IPO in the U.S.
28th Jul 202012:00 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.